Cassava Sciences | Lånekapital



Loan Capital Endring Dato
Abbott USD 12.62B 200M 2024-12
Amgen USD 56.55B 305M 2024-12
Biogen USD 4.55B 1.4M 2024-12
Cassava Sciences USD 0 0 2024-12
Eisai JPY 99.82B 9M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Geron USD 118.48M 106.2M 2024-12
J&J USD 30.65B 638M 2024-12
Merck USD 34.46B 520M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12



Cassava Sciences Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.